Inverse stage migration in patients undergoing radical prostatectomy: Results of 8916 European patients treated within the last decade

BJU International

Volumn 108, Issue 8, 2011, Pages 1256-1261

  Budäus, Lars ^a   Spethmann, Jan ^a   Isbarn, Hendrik ^a   Schmitges, Jan ^a   Beesch, Laura ^a   Haese, Alexander ^a   Salomon, Georg ^a   Schlomm, Thorsten ^a   Fisch, Margit ^a   Heinzer, Hans ^a   Huland, Hartwig ^a   Graefen, Markus ^a   Steuber, Thomas ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

grade migration; PSA; radical prostatectomy; stage migration

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INVASION; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; EUROPE; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RISK FACTOR; TERTIARY HEALTH CARE; TREATMENT RESPONSE;

ADULT; AGED; GERMANY; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 80053384631     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09982.x     Document Type: Article

References (34)

1. Jemal A, Siegel R, Ward E, et al,. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96 (Pubitemid 351521864)
2. Shao YH, Demissie K, Shih W, et al,. Contemporary risk profile of prostate cancer in the United States. J Natl Cancer Inst 2009; 101: 1280-3
3. Lu-Yao GL, Albertsen PC, Moore DF, et al,. Outcomes of localized prostate cancer following conservative management. JAMA 2009; 302: 1202-9
4. Schroder FH, Hugosson J, Roobol MJ, et al,. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360: 1320-8
5. Gallina A, Chun FK, Suardi N, et al,. Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer. BJU Int 2008; 101: 1513-8 (Pubitemid 351704026)
6. Budaus L, Isbarn H, Schlomm T, et al,. Current technique of open intrafascial nerve-sparing retropubic prostatectomy. Eur Urol 2009; 56: 317-24
7. Graefen M, Walz J, Huland H,. Open retropubic nerve-sparing radical prostatectomy. Eur Urol 2006; 49: 38-48 (Pubitemid 41789952)
8. True LD,. Surgical pathology examination of the prostate gland. Practice survey by American society of clinical pathologists. Am J Clin Pathol 1994; 102: 572-9 (Pubitemid 24337547)
9. Partin AW, Kattan MW, Subong EN, et al,. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 1997; 277: 1445-51 (Pubitemid 27208886)
10. D'Amico AV, Whittington R, Malkowicz SB, et al,. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-74 (Pubitemid 28445094)
11. Welch HG, Albertsen PC,. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst 2009; 101: 1325-9
12. Albertsen PC,. Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol. Austria J Urol 2002; 168: 880-1
13. Noldus J, Graefen M, Haese A, et al,. Stage migration in clinically localized prostate cancer. Eur Urol 2000; 38: 74-8 (Pubitemid 30418019)
14. Steuber T, Graefen M, Haese A, et al,. Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy. J Urol 2006; 175: 939-44 (Pubitemid 43200025)
15. Gerber GS, Thisted RA, Chodak GW, et al,. Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis. Eur Urol 1997; 32: 385-90 (Pubitemid 27501033)
16. Augustin H, Hammerer P, Graefen M, et al,. Intraoperative and perioperative morbidity of contemporary radical retropubic prostatectomy in a consecutive series of 1243 patients: results of a single center between 1999 and 2002. Eur Urol 2003; 43: 113-8 (Pubitemid 36221962)
17. Shikanov SA, Thong A, Gofrit ON, et al,. Robotic laparoscopic radical prostatectomy for biopsy Gleason 8 to 10: prediction of favorable pathologic outcome with preoperative parameters. J Endourol 2008; 22: 1477-81
18. Freedland SJ, Partin AW, Humphreys EB, et al,. Radical prostatectomy for clinical stage T3a disease. Cancer 2007; 109: 1273-8 (Pubitemid 46466553)
19. Heidenreich A, Aus G, Bolla M, et al,. [EAU guidelines on prostate cancer]. Actas Urol Esp 2009; 33: 113-26
20. Hsu CY, Joniau S, Oyen R, et al,. Outcome of surgery for clinical unilateral T3a prostate cancer: a single-institution experience. Eur Urol 2007; 51: 121-8; discussion 8-9
21. Ward JF, Slezak JM, Blute ML, et al,. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int 2005; 95: 751-6 (Pubitemid 40547200)
22. Van Der Poel HG, Moonen L, Horenblas S,. Sequential treatment for recurrent localized prostate cancer. J Surg Oncol 2008; 97: 377-82 (Pubitemid 351466377)
23. Walz J, Gallina A, Saad F, et al,. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol 2007; 25: 3576-81 (Pubitemid 47372594)
24. Cowen ME, Halasyamani LK, Kattan MW,. Predicting life expectancy in men with clinically localized prostate cancer. J Urol 2006; 175: 99-103 (Pubitemid 41797102)
25. Turpen R, Rosser CJ,. Focal therapy for prostate cancer: revolution or evolution? BMC Urol 2009; 9: 2
26. Heidenreich A, Aus G, Bolla M, et al,. EAU guidelines on prostate cancer. Eur Urol 2008; 53: 68-80 (Pubitemid 350166735)
27. Cooperberg MR, Broering JM, Carroll PR,. Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer. J Clin Oncol 2010; 28: 1117-23
28. Epstein JI, Allsbrook WC Jr, Amin MB, et al,. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005; 29: 1228-42 (Pubitemid 41232997)
29. Montironi R, Vela-Navarrete R, Lopez-Beltran A, et al,. 2005 update on pathology of prostate biopsies with cancer. Eur Urol 2006; 49: 441-7 (Pubitemid 43259550)
30. Albertsen PC, Hanley JA, Barrows GH, et al,. Prostate cancer and the Will Rogers phenomenon. J Natl Cancer Inst 2005; 97: 1248-53 (Pubitemid 41535365)
31. Tumorzentrum Brandenburg: Sachbericht. 2007
32. Weissbach L, Altwein J,. Active surveillance or active treatment in localized prostate cancer? Dtsch Arztebl Int 2009; 106: 371-6
33. Ablatherm. Investor relations. 2010
34. Rübben H, Bloch M, Wullich B,. HAROW-STUDY. 2010